Alahist Cf
Product Images NDC 50991-784

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Alahist Cf (NDC 50991-784). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Poly Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Alahistlabel (Alahistlabel)

Label for Alahist CF Tablets by Poly Pharmaceuticals, Inc., with NDC 50991-784-90. The label includes storage instructions, a barcode, and space for lot and expiration date. The product is described as containing 90 tablets, with dosages indicated for each active ingredient including dextromethorphan hydrobromide and phenylephrine HCl.*

FDA Label Image

Labelbooklet (Labelbooklet)

Drug Facts text panels for Alahist CF Tablets by Poly Pharmaceuticals, Inc. include active ingredients, purposes, uses, warnings, directions, inactive ingredients, storage information, and contact details. The panels provide dosage instructions, precautions for special populations, and safety advice. The label also displays the UPC barcode, manufacturer information, and usual dosage notes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.